Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
5685.0000
-1.50
(
-0.03
%)
NSE
Nov 28, 2025
15:31 PM
Near 52W High of ₹5868.00
Volume:
57,067
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
08 Aug 2020
5685.00
-0.03%
Alkem Labs (BUY): Gross margin beat sustainable; stronger FCF to support rerating
Buy:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3600
Target
BOB Capital Markets Ltd.
Alkem Labs posted a solid Q1 EBITDA beat led partly by one-offs.
Alkem Laboratories L.. has an
average target
of 5562.33 from 3 brokers.
More from Alkem Laboratories Ltd.
Recommended
Five Interesting Stocks Today - November 28, 2025
The Baseline |
28 Nov 2025, 04:33PM
Market closes lower, dragged down by Hardware Technology and Telecommunications Equipment sectors
Trendlyne Marketwatch |
28 Nov 2025, 04:00PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021